Non-covalent immunoproteasome inhibitors induce cell cycle arrest in multiple myeloma MM.1R cells
Open Access
- 1 January 2019
- journal article
- research article
- Published by Taylor & Francis in Journal of Enzyme Inhibition and Medicinal Chemistry
- Vol. 34 (1) , 1307-1313
Abstract
Proteasome inhibition is a promising strategy for the treatment of multiple myeloma; unfortunately, this disease is often associated with an increasing chemoresistance. One novel approach may be to target the immunoproteasome, a proteasomal isoform mainly present in cells of hematopoietic origin. We investigated the activity of a panel of amides against immunoproteasome core particles as potential agents for the treatment of multiple myeloma (MM). Amide 6 showed an ideal profile since it was able to inhibit both the chymotrypsin-like activities of the immunoproteasome with Ki values of 4.90 µM and 4.39 µM for β1i and β5i, respectively, coupled with an EC50 =17.8 µM against MM.1R cells. Compound 6 inhibited also ubiquitinated protein degradation and was able to act on different phases of MM cell cycle reducing the levels of cyclin A/CDK1, cyclin B/CDK1 and cyclin D/CDK4/6 complexes, which turns in cell cycle arrest.Keywords
Funding Information
- Research & Mobility Program 2015
This publication has 21 references indexed in Scilit:
- Prolonged early G1 arrest by selective CDK4/CDK6 inhibition sensitizes myeloma cells to cytotoxic killing through cell cycle–coupled loss of IRF4Blood, 2012
- Immunoproteasomes2012
- Development of Novel Peptidomimetics Containing a Vinyl Sulfone Moiety as Proteasome InhibitorsChemMedChem, 2011
- Bortezomib Induces Nuclear Translocation of IκBα Resulting in Gene-Specific Suppression of NF-κB–Dependent Transcription and Induction of Apoptosis in CTCLMolecular Cancer Research, 2011
- Carfilzomib can induce tumor cell death through selective inhibition of the chymotrypsin-like activity of the proteasomeBlood, 2009
- Proteasome Inhibitors Induce Death but Activate NF-κB on Endometrial Carcinoma Cell Lines and Primary Culture ExplantsJournal of Biological Chemistry, 2006
- Ageing, hormonal behaviour and cyclin D1 in ductal breast carcinomasThe Breast, 2006
- RETRACTED: Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI–CDK–cyclin cascade, and caspase 3 and PARP cleavagesCarcinogenesis, 2004
- Proteasome Inhibitors Induce Inhibitory κB (IκB) Kinase Activation, IκBα Degradation, and Nuclear Factor κB Activation in HT-29 CellsMolecular Pharmacology, 2004
- Characterization of the MM.1 human multiple myeloma (MM) cell linesExperimental Hematology, 2003